These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23540800)

  • 1. Drug-induced parkinsonism.
    López-Sendón J; Mena MA; de Yébenes JG
    Expert Opin Drug Saf; 2013 Jul; 12(4):487-96. PubMed ID: 23540800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced parkinsonism in the elderly: incidence, management and prevention.
    López-Sendón JL; Mena MA; de Yébenes JG
    Drugs Aging; 2012 Feb; 29(2):105-18. PubMed ID: 22250585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism in a nursing home: underrecognition.
    Friedman JH; Fernandez HH; Trieschmann MM
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):39-41. PubMed ID: 15018697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of recognition of drug-induced parkinsonism in the elderly.
    Esper CD; Factor SA
    Mov Disord; 2008 Feb; 23(3):401-4. PubMed ID: 18067180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
    Jeong S; Cho H; Kim YJ; Ma HI; Jang S
    PLoS One; 2021; 16(3):e0247354. PubMed ID: 33647030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
    Munhoz RP; Werneck LC; Teive HA
    Clin Neurol Neurosurg; 2010 Jun; 112(5):431-5. PubMed ID: 20347518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
    Mahmoud F; Tampi RR
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.
    Bondon-Guitton E; Perez-Lloret S; Bagheri H; Brefel C; Rascol O; Montastruc JL
    Mov Disord; 2011 Oct; 26(12):2226-31. PubMed ID: 21674626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction in drug induced parkinsonism (DIP).
    Kim YD; Kim JS; Chung SW; Song IU; Yang DW; Hong YJ; Kim YI; Ahn KJ; Kim HT; Lee KS
    Arch Gerontol Geriatr; 2011; 53(2):e222-6. PubMed ID: 21163539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced parkinsonism.
    Shin HW; Chung SJ
    J Clin Neurol; 2012 Mar; 8(1):15-21. PubMed ID: 22523509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced parkinsonism.
    Mena MA; de Yébenes JG
    Expert Opin Drug Saf; 2006 Nov; 5(6):759-71. PubMed ID: 17044803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.
    Knol W; Keijsers CJ; Jansen PA; van Marum RJ
    J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and drug-induced Parkinsonism: a case-control study.
    Ma HI; Kim JH; Chu MK; Oh MS; Yu KH; Kim J; Hahm W; Kim YJ; Lee BC
    J Neurol Sci; 2009 Sep; 284(1-2):140-3. PubMed ID: 19467671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs inducing or aggravating parkinsonism: a review.
    Marti-Massó JF; Poza JJ; Lopez de Munain A
    Therapie; 1996; 51(5):568-77. PubMed ID: 9138399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs with anticholinergic properties: a current perspective on use and safety.
    Gerretsen P; Pollock BG
    Expert Opin Drug Saf; 2011 Sep; 10(5):751-65. PubMed ID: 21635190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced parkinsonism].
    Kuzuhara S
    Nihon Rinsho; 1997 Jan; 55(1):112-7. PubMed ID: 9014432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.